Skip to main
PODD

Insulet (PODD) Stock Forecast & Price Target

Insulet (PODD) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 44%
Hold 11%
Sell 6%
Strong Sell 0%

Bulls say

Insulet is a strong performer in the healthcare industry, with a track record of strong earnings and growth. Its innovative Omnipod system provides a competitive advantage in the market and has a large user base, making it a solid investment. However, its stock price may be volatile due to market conditions and potential competition, so careful monitoring is advised.

Bears say

Insulet is facing a deceleration in growth due to conservatism in their guidance, tougher year-over-year comparisons, and potential softness in the market related to insurance deductible resets and ACA subsidy expirations. Despite these challenges, the company remains confident in its long-term growth potential and has several growth drivers in place such as the Omnipod 5 AID system and expanded T2D patient population. However, there is a risk of slower adoption of T2D patients and potential competition in the market.

Insulet (PODD) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 44% recommend Buy, 11% suggest Holding, 6% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Insulet and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Insulet (PODD) Forecast

Analysts have given Insulet (PODD) a Buy based on their latest research and market trends.

According to 18 analysts, Insulet (PODD) has a Buy consensus rating as of May 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $276.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $276.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Insulet (PODD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.